Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
This randomized phase III trial studies compliance to a mercaptopurine treatment intervention
compared to standard of care in younger patients with acute lymphoblastic leukemia that has
had a decrease in or disappearance of signs and symptoms of cancer (remission). Assessing
ways to help patients who have acute lymphoblastic leukemia to take their medications as
prescribed may help them in taking their medications more consistently and may improve
treatment outcomes.